Net Cash Provided by (Used in) Financing Activities of USANA HEALTH SCIENCES INC from 02 Jan 2010 to 03 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
USANA HEALTH SCIENCES INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 02 Jan 2010 to 03 Jan 2026.
  • USANA HEALTH SCIENCES INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 29 Mar 2025 was $14,467,000, a 21% decline year-over-year.
  • USANA HEALTH SCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $40,603,000, a 525% decline from 2024.
  • USANA HEALTH SCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9,553,000.
  • USANA HEALTH SCIENCES INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $14,237,000, a 53% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

USANA HEALTH SCIENCES INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $40,603,000 -$50,156,000 -525% 29 Dec 2024 03 Jan 2026 10-K 16 Mar 2026 2025 FY
2024 $9,553,000 +$23,790,000 31 Dec 2023 28 Dec 2024 10-K 16 Mar 2026 2025 FY
2023 $14,237,000 +$15,851,000 +53% 01 Jan 2023 30 Dec 2023 10-K 16 Mar 2026 2025 FY
2022 $30,088,000 +$151,324,000 +83% 02 Jan 2022 31 Dec 2022 10-K 12 Mar 2025 2023 FY
2021 $181,412,000 -$121,970,000 -205% 03 Jan 2021 01 Jan 2022 10-K 27 Feb 2024 2023 FY
2020 $59,442,000 +$92,610,000 +61% 29 Dec 2019 02 Jan 2021 10-K 28 Feb 2023 2022 FY
2019 $152,052,000 -$46,775,000 -44% 30 Dec 2018 28 Dec 2019 10-K 01 Mar 2022 2022 FY
2018 $105,277,000 -$54,961,000 -109% 31 Dec 2017 29 Dec 2018 10-K 02 Mar 2021 2020 FY
2017 $50,316,000 +$14,544,000 +22% 01 Jan 2017 30 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $64,860,000 -$15,703,000 -32% 03 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $49,157,000 +$63,858,000 +57% 04 Jan 2015 02 Jan 2016 10-K 28 Feb 2018 2017 FY
2014 $113,015,000 -$102,850,000 -1012% 29 Dec 2013 03 Jan 2015 10-K 17 Mar 2015 2014 FY
2013 $10,165,000 +$54,377,000 +84% 30 Dec 2012 28 Dec 2013 10-K 17 Mar 2015 2014 FY
2012 $64,542,000 -$31,170,000 -93% 01 Jan 2012 29 Dec 2012 10-K 17 Mar 2015 2014 FY
2011 $33,372,000 -$23,795,000 -248% 02 Jan 2011 31 Dec 2011 10-K 13 Mar 2014 2013 FY
2010 $9,577,000 +$19,925,000 +68% 03 Jan 2010 01 Jan 2011 10-K 11 Mar 2013 2012 FY
2009 $29,502,000 04 Jan 2009 02 Jan 2010 10-K 14 Mar 2012 2011 FY

USANA HEALTH SCIENCES INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $14,467,000 -$2,521,000 -21% 29 Dec 2024 29 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $11,946,000 -$8,747,000 -273% 31 Dec 2023 30 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $3,199,000 +$16,394,000 +84% 01 Jan 2023 01 Apr 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $19,593,000 +$50,882,000 +72% 02 Jan 2022 02 Apr 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $70,475,000 -$11,623,000 -20% 03 Jan 2021 03 Apr 2021 10-Q 11 May 2022 2022 Q1
Q1 2020 $58,852,000 -$27,439,000 -87% 29 Dec 2019 28 Mar 2020 10-Q 11 May 2021 2021 Q1
Q1 2019 $31,413,000 -$28,162,000 -866% 30 Dec 2018 30 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $3,251,000 31 Dec 2017 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2014 $1,856,000 +$19,756,000 29 Dec 2013 29 Mar 2014 10-Q 07 May 2014 2014 Q1
Q1 2013 $17,900,000 -$18,076,000 -10270% 30 Dec 2012 30 Mar 2013 10-Q 07 May 2014 2014 Q1
Q1 2012 $176,000 +$8,663,000 01 Jan 2012 31 Mar 2012 10-Q 07 May 2013 2013 Q1
Q1 2011 $8,487,000 02 Jan 2011 02 Apr 2011 10-Q 10 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.